Answers are grounded in this paper and cite their sources.
Relapses occur in 15%-25% of patients with leucine-rich glioma-inactivated 1 antibody (LGI1-Ab) autoimmune encephalitis and may cause additional disability. In this study, we clinically characterized the relapses and identified factors predicting their occurrence.
No takes yet. Share an insight, caveat, or question.
Campetella et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: